11![PETITION TO THE HONOURABLE SPEAKER AND MEMBERS OF THE HOUSE OF REPRESENTATIVES FROM THE CYSTIC FIBROSIS (CF) COMMUNITY OF AUSTRALIA REASONS FOR PETITION: There is a desperate and urgent need to have Kalydeco (ivacaftor), PETITION TO THE HONOURABLE SPEAKER AND MEMBERS OF THE HOUSE OF REPRESENTATIVES FROM THE CYSTIC FIBROSIS (CF) COMMUNITY OF AUSTRALIA REASONS FOR PETITION: There is a desperate and urgent need to have Kalydeco (ivacaftor),](https://www.pdfsearch.io/img/f8e9378e67d1609f0c86d1e277a627eb.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2014-07-21 11:22:06
|
---|
12![12.00% p.a. CHF Kick-In GOAL Linked to worst of Basilea / Gilead / Vertex Pharmaceuticals Issued by UBS AG, London Branch Cash settled; Quanto Style SVSP/EUSIPA Product Type: Barrier Reverse Convertible[removed]Valor: 272 12.00% p.a. CHF Kick-In GOAL Linked to worst of Basilea / Gilead / Vertex Pharmaceuticals Issued by UBS AG, London Branch Cash settled; Quanto Style SVSP/EUSIPA Product Type: Barrier Reverse Convertible[removed]Valor: 272](https://www.pdfsearch.io/img/3d383ba28c61ea6e07da24d8e3f6417b.jpg) | Add to Reading ListSource URL: www.cash.chLanguage: English - Date: 2015-03-13 10:25:33
|
---|
13![June 24, 2014 Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have Two June 24, 2014 Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have Two](https://www.pdfsearch.io/img/720540ad4efc12b14993344b3f56e59b.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2014-06-26 20:51:01
|
---|
14![WINTER[removed]Plus: Rosey Days WINTER[removed]Plus: Rosey Days](https://www.pdfsearch.io/img/85882b9ff12c8ce10fb8eea81df6d9fe.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2014-07-09 23:56:38
|
---|
15![Session 1: Generating and Interpreting Data in Ultra-rare Patient Subsets in Non-oncologic Diseases Session 1: Generating and Interpreting Data in Ultra-rare Patient Subsets in Non-oncologic Diseases](https://www.pdfsearch.io/img/60fdec1fb4ba4218a6b176d4300173ec.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
16![CFTNEWS AUTUMN[removed]Autumn Cystic Fibrosis CFTNEWS AUTUMN[removed]Autumn Cystic Fibrosis](https://www.pdfsearch.io/img/56812babdc9d407d2172ae3d5383f305.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2013-05-05 21:03:43
|
---|
17![Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]th Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]th](https://www.pdfsearch.io/img/f57e52b979167b940fc00a193cd59614.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English |
---|
18![Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]October 2014 Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]October 2014](https://www.pdfsearch.io/img/a9ed79deb1a8d7a98f57393e8598dd77.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2014-10-25 19:53:08
|
---|
19![THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014 THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014](https://www.pdfsearch.io/img/5f5cefdbcf3325dd7493dbb89dfb2bc9.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2014-10-25 18:54:58
|
---|
20![Microsoft Word - Document1 Microsoft Word - Document1](https://www.pdfsearch.io/img/c73dc9f78a48d759a6a982d0a7eda5ca.jpg) | Add to Reading ListSource URL: www.cysticfibrosis.org.auLanguage: English - Date: 2013-02-26 23:38:03
|
---|